Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Consumer Perception of an Experimental Mouthwash After a Single Use in Dry Mouth Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03005041
Recruitment Status : Completed
First Posted : December 29, 2016
Results First Posted : April 3, 2018
Last Update Posted : July 19, 2018
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

Brief Summary:
The purpose of this study is to investigate the consumer perception of an experimental mouthwash formulation in population with dry mouth

Condition or disease Intervention/treatment Phase
Xerostomia Other: Biotene mouthwash Other: Bottled mineral water Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 56 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Other
Official Title: A Clinical Study Evaluating the Consumer Perception of an Experimental Mouthwash Formulation After a Single Use
Actual Study Start Date : August 31, 2016
Actual Primary Completion Date : October 19, 2016
Actual Study Completion Date : October 19, 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Dry Mouth

Arm Intervention/treatment
Experimental: Test Product 1
Participants will rinse their mouth with 15 mL of the product swishing for 30 seconds.
Other: Biotene mouthwash
Participants will rinse their mouth with 15 mL of Biotene mouthwash swishing for 30 seconds.

Test Product 2
Participants will rinse their mouth with 15 mL of the water swishing for 30 seconds. Participants then spit out the water.
Other: Bottled mineral water
Participants will rinse their mouth with 15 mL of the water swishing for 30 seconds.




Primary Outcome Measures :
  1. Number of Participants With Response to Post-Product Use Questionnaires 1 (PPUQ 1); Question No.1 [ Time Frame: Within 2 minutes post product use ]
    Participants answered the following question, Q1: how much do you agree or disagree with the following statements about this product, having used it? "This product is gentle": disagree strongly, disagree, neither agree nor disagree, agree, or agree strongly. There was no formal statistical hypothesis to be tested for this outcome..


Secondary Outcome Measures :
  1. Number of Participants With Response to Post-Product Use Questionnaires 1 (PPUQ 1); Question No. 3-7 [ Time Frame: Within 2 minutes post product use ]
    Participants answered the following questions, Q3: Which of following statements best describes how much you liked product overall? liked it-extremely, very much, somewhat, slightly, did not like it that much, did not like it at all. Q 4: Which of the following statements best describes how much you liked overall flavor of rinse? liked it-extremely, very much, somewhat, slightly, did not like it that much, did not like it at all. Q 5: How you would rate flavor intensity of oral rinse? strongest flavor imaginable, very strong, strong, moderate, weak, barely detectable, no flavor at all. Q 6: Did you experience any of following sensations in your mouth & how strong was sensation? moisturizing, soothing, refreshing, tingling, numbing, burning, or drying out. Participants who selected "None" for a particular sensation, did not complete Q 7 for that sensation: When did you experience sensations in your mouth? initially, during use, or after use.

  2. Number of Participants With Response to Post-Product Use Questionnaires 2 (PPUQ 2) [ Time Frame: Within 30 ± 5 minutes post product use ]
    Participants answered the following question; Q1: Are you experiencing any of the following sensations in your mouth and how strong is the sensation? moisturizing, soothing, refreshing, tingling, numbing, burning, or drying out. Q2: Would you continue use of the product? (Yes or No)

  3. Number of Participants With Response to Product Performance Attribute Questionnaire (PPAQ) [ Time Frame: Within 5 minutes post product use ]
    Participants rated the following criteria on a scale of 1 to 5(1=Poor, 2= Fair, 3= Good, 4= Very good, 5= Excellent) as follows: 1. Having an immediate dry mouth relief, 2. Having an immediate lubricating effect, 3. Having an immediate moisturizing effect.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 84 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Demonstrates understanding of the study procedures, restrictions and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form
  • Aged 18 - 84 years inclusive
  • Good general and mental health with, in the opinion of the investigator or medically qualified designee no clinically significant and relevant abnormalities in medical history or upon oral examination
  • Participant reports having a feeling of a dry mouth according to the Dry Mouth Screening Questionnaire (DMSQ) (Subject must answer at least 2 out of the 4 questions with 'agree a little', 'agree' or 'strongly agree' at the Screening Visit (Visit 1). Participants with un-stimulated whole salivary flow rate of ≤0.1 ml/min at the Screening Visit (Visit 1).
  • Participants with un-stimulated whole salivary flow rate of ≤0.1 ml/min ATH the Screening Visit (Visit 1).
  • Understands and is willing, able and likely to comply with all study procedures and restrictions

Exclusion Criteria:

  • Women who are known to be pregnant or who are intending to become pregnant over the duration of the study or have a positive urine pregnancy test at the Screening Visit
  • Women who are breast-feeding
  • Participant is currently undergoing radiotherapy and/or chemotherapy treatment
  • Any condition the investigator identifies that can confound the participant's ability to properly participate in the study e.g. Alzheimer's Disease
  • Participant with untreated oral mucosal disease which in the opinion of the investigator could interfere with the study (e.g. current oral ulceration)
  • Evidence of gross intra-oral neglect or need for extensive dental therapy
  • Denture wearer (complete dentures)
  • Participant not on stable doses of prescription systemic parasympathetic medications (e.g. Pilocarpine), for the treatment of the feeling of dry mouth
  • Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients
  • Participation in another clinical study (including cosmetic studies) or receipt of an investigational drug within 14 days of the screening visit
  • Previous participation in this study
  • Recent history (within the last 1 year) of alcohol or other substance abuse
  • An employee of the sponsor or the clinical study team or members of their immediate family. Students and employees of the Tufts University School of Dental Medicine not associated with the clinical trials team are eligible to participate. Students and employees will not be specifically targeted for enrollment
  • Non-English speaking Participants will not be enrolled in the study. Participants must be able to read and write in English

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03005041


Locations
Layout table for location information
United States, Massachusetts
GSK Investigational Site
Boston, Massachusetts, United States, 02111
Sponsors and Collaborators
GlaxoSmithKline
Investigators
Layout table for investigator information
Study Director: GSK Clinical Trials GlaxoSmithKline

Layout table for additonal information
Responsible Party: GlaxoSmithKline
ClinicalTrials.gov Identifier: NCT03005041     History of Changes
Other Study ID Numbers: 205067
First Posted: December 29, 2016    Key Record Dates
Results First Posted: April 3, 2018
Last Update Posted: July 19, 2018
Last Verified: August 2017

Additional relevant MeSH terms:
Layout table for MeSH terms
Xerostomia
Salivary Gland Diseases
Mouth Diseases
Stomatognathic Diseases